Accent Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Accent Capital Management's LLY Position: Q2 2026 in Review
Accent Capital Management reduced its Eli Lilly (LLY) stake by 5.8% in Q2 2026, selling an estimated $335K and leaving 5,294 shares worth $6.35M. The position accounts for 2.74% of the portfolio, ranked #10.
Accent Capital Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Accent Capital Management held 5,294 shares of Eli Lilly worth $6.35M as of Q2 2026.
- Accent Capital Management sold 328 Eli Lilly shares in Q2 2026, an estimated $335K.
- Eli Lilly made up 2.74% of Accent Capital Management's portfolio in Q2 2026, its #10 holding.
- Accent Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.